349 studies found for:    Open Studies | "Embolism and Thrombosis"
Show Display Options
Rank Status Study
21 Recruiting Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Condition: Venous Thromboembolism (VTE)
Interventions: Drug: Betrixaban;   Drug: Enoxaparin
22 Unknown  Rivaroxaban Safety Profile in the Prophylaxis of Venous Thromboembolism After Hip Fracture Surgery
Condition: Open Fracture of Hip
Intervention:
23 Recruiting DDS-25 Gauge in Patients With Macular Edema Secondary to Retinal Vein Occlusion (RVO)
Conditions: Macular Edema;   Retinal Vein Occlusion
Intervention: Device: Dexamethasone drug delivery system (DDS-25)
24 Unknown  ICU Venous Thromboembolism Incidence Study in a Chinese Population
Condition: Venous Thromboembolism
Intervention:
25 Recruiting Cellular and Tissue Based Therapy Registry
Conditions: Diabetic Foot Ulcers;   Venous Stasis Ulcer;   Pressure Ulcer;   Chronic Non Healing Wound;   Surgical Wound Dehiscence
Intervention: Biological: Cellular and tissue based products
26 Recruiting Evaluation of the Use of Apixaban in Prevnetion of Thromboembolic Disease in Patients With Myeloma Trated With iMiDs
Conditions: Myeloma;   Venous Thromboembolism
Intervention: Drug: Apixaban
27 Recruiting Measurement of D-Dimer Levels in Patients With Confirmed Deep Vein Thrombosis
Condition: Deep Venous Thrombosis
Intervention:
28 Recruiting Tolerability , PK/PD and Safety of Dabigatran Etexilate Oral Liquid Formulation in Children < 1 Year of Age
Condition: Venous Thromboembolism
Intervention: Drug: dabigatran
29 Recruiting An Observational Cohort Study to Investigate the Risk of Thromboembolic Events in Patients Receiving Kcentra® or Plasma to Reverse Vitamin K Antagonist (VKA) Therapy in the Setting of Acute Major Bleeding
Condition: Hemorrhage
Interventions: Biological: Kcentra®;   Biological: Plasma
30 Unknown  Diagnostic Approach of Deep Vein Thrombosis in Primary Care
Condition: Thrombosis
Intervention: Other: D Dimer and ultrasonography
31 Unknown  The Effect of Vasopressors on the Anti Xa Response to Enoxaparin in Critically Ill Patients
Conditions: Venous Thrombosis;   Critical Illness
Intervention: Drug: Enoxaparine
32 Recruiting Clinical Predictors for Venous Thromboembolism in Patients With a History of Thrombosis
Condition: Thromboembolic Disease Recurrent
Intervention:
33 Unknown  Retinal Endo Vascular Surgery for Central Retinal Vein Occlusion
Condition: Central Retinal Vein Occlusion
Intervention: Procedure: Retinal endo vascular surgery
34 Recruiting Ziv-aflibercept in Eyes With Retinal Diseases and Poor Vision-phase I
Conditions: Age Related Macular Degeneration;   Central Retinal Vein Occlusion
Intervention: Drug: ziv-aflibercept drug
35 Recruiting Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis
Condition: Coronary Artery Bypass
Interventions: Drug: Prasugrel;   Drug: Placebo
36 Recruiting Effect of Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis
Conditions: Liver Cirrhosis;   Portal Vein;   Venous Thrombosis;   Varicose Veins;   Hemorrhage
Interventions: Drug: Somatostatin and its analogs;   Procedure: Endoscopic sclerotherapy, endoscopic variceal ligation, endoscopic tissue glue injection
37 Recruiting Treatment of Blood Clots in Children With Cancer
Condition: Venous Thromboembolism
Intervention: Drug: Fragmin
38 Recruiting Pharmacokinetics of Enoxaparin in Intensive Care Patients
Condition: Venous Thromboembolism
Intervention: Drug: Enoxaparin
39 Recruiting Retinal Vessel Diameter in Branch Retinal Vein Occlusion
Condition: Branch Retinal Vein Occlusion
Intervention:
40 Recruiting Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Fair Vision
Conditions: Branch Retinal Vein Occlusion;   Macular Edema
Interventions: Drug: Ranibizumab;   Device: Sham injection;   Procedure: Rescue laser

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years